Am J Psychiatry. 1984 Nov;141(11):1356-64.

A new rating scale for Alzheimer's disease.

Abstract

A new rating instrument, the Alzheimer's Disease Assessment Scale, was designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic of persons with Alzheimer's disease. Item descriptions, administration procedures, and scoring are outlined. Twenty-seven subjects with Alzheimer's disease and 28 normal elderly subjects were rated on 40 items. Twenty-one items with significant intraclass correlation coefficients for interrater reliability (range, .650-.989) and significant Spearman rank-order correlation coefficients for test-retest reliability (range, .514-1) constitute the final scale. Subjects with Alzheimer's disease had significantly more cognitive and noncognitive dysfunction than the normal elderly subjects.

PMID:: 6496779; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Grant Support

Publication Types

MeSH Terms

Grant Support

AG-02219/AG/NIA NIH HHS/United States

LinkOut - more resources

Full Text Sources

Silverchair Information Systems

Medical

Supplemental Content

Related citations

[Spanish adaptation of the Alzheimer's disease assessment scale (ADAS)]. [Actas Luso Esp Neurol Psiquiatr Cienc Afine...]
[Spanish adaptation of the Alzheimer's disease assessment scale (ADAS)].
Manzano JM, Llorca G, Ledesma A, López-Ibor JJ. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994 Mar-Apr; 22(2):64-70.
The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects. [Int J Geriatr Psychiatry. 2006]
The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H, Gedizlioglu M, Akyel S, Aslaner T, Eser E. Int J Geriatr Psychiatry. 2006 Mar; 21(3):259-65.
A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. [Am J Psychiatry. 1993]
A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.
Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL. Am J Psychiatry. 1993 Dec; 150(12):1806-12.
Review Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. [Int Psychogeriatr. 2008]
Review Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease.
Reisberg B, Gauthier S. Int Psychogeriatr. 2008 Feb; 20(1):1-16.
Review Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease. [J Clin Psychiatry. 1998]
Review Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
Cummings JL, Masterman DL. J Clin Psychiatry. 1998; 59 Suppl 13:23-30.

See reviews... See all...

Cited by over 100 PubMed Central articles

Effects of lacunar infarctions on cognitive impairment in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. [J Clin Neurol. 2011]
Effects of lacunar infarctions on cognitive impairment in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Lee JS, Choi JC, Kang SY, Kang JH, Na HR, Park JK. J Clin Neurol. 2011 Dec; 7(4):210-4. Epub 2011 Dec 29.
A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease. [Dement Geriatr Cogn Dis Extra. 2011]
A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.
Nakamura Y, Imai Y, Shigeta M, Graf A, Shirahase T, Kim H, Fujii A, Mori J, Homma A. Dement Geriatr Cogn Dis Extra. 2011 Jan; 1(1):163-79. Epub 2011 Jun 24.
The effect of vascular risk factors on the efficacy of rivastigmine patch and capsule treatment in Alzheimer's disease. [Dement Geriatr Cogn Dis Extra. 2011]
The effect of vascular risk factors on the efficacy of rivastigmine patch and capsule treatment in Alzheimer's disease.
Farlow MR, Doraiswamy PM, Meng X, Cooke K, Somogyi M. Dement Geriatr Cogn Dis Extra. 2011 Jan; 1(1):150-62. Epub 2011 Jun 24.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

A new rating scale for Alzheimer's disease.
A new rating scale for Alzheimer's disease.
Am J Psychiatry. 1984 Nov ;141(11):1356-64.

PubMed
Eelgrass (Zostera marina L.) in the Gulf of California:.
Eelgrass (Zostera marina L.) in the Gulf of California:.
Science. 1973 Jul 27 ;181(4097):355-6.

PubMed
EXPEDITION TO SERILAND.
EXPEDITION TO SERILAND.
Science. 1896 Apr 3 ;3(66):493-505.

PubMed
An improved method for patch clamp recording and calcium imaging of neurons in t...
An improved method for patch clamp recording and calcium imaging of neurons in the intact dorsal root ganglion in rats.
J Neurosci Methods. 2008 Aug 15 ;173(1):74-82. Epub 2008 Jun 7 .

PubMed
California Men's Health Study (CMHS): a multiethnic cohort in a managed care set...
California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting
BMC Public Health. 2006; 6: 172.

PMC

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: